Cleared Traditional

K201359 - ECG Cables and Leadwires

K201359 is the FDA 510(k) clearance for ECG Cables and Leadwires by Xinkang Medical Instrument Co. , Ltd.. It is a Class 2 Cardiovascular device (product code DSA) cleared through the Traditional 510(k) pathway after a 133-day FDA review.

K201359 · Xinkang Medical Instrument Co. , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2020
Decision
133d
Days
Class 2
Risk

K201359 is an FDA 510(k) clearance for the ECG Cables and Leadwires. Classified as Cable, Transducer And Electrode, Patient, (including Connector) (product code DSA), Class II - Special Controls.

Submitted by Xinkang Medical Instrument Co. , Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on October 1, 2020 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2900 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Xinkang Medical Instrument Co. , Ltd. devices

Submission Details

510(k) Number K201359 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 21, 2020
Decision Date October 01, 2020
Days to Decision 133 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 125d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DSA Cable, Transducer And Electrode, Patient, (including Connector)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2900
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Shenzhen Joyantech Consulting Co., Ltd.
Field Fu

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DSA Cable, Transducer And Electrode, Patient, (including Connector)

All 47
Devices cleared under the same product code (DSA) and FDA review panel - the closest regulatory comparables to K201359.
PCA-C1 series Patient Cable
K200722 · QT Medical, Inc. · Jun 2021
Patient Monitoring Cables
K203635 · Jkh USA, LLC · Feb 2021
Multi-LinkTM X2 ECG Adapter and Leadwires
K200510 · Vyaire Medical, Inc. · Oct 2020
AtriAmp, AtriAmp - Pacing Cable Medtronic Connector, AtriAmp - Pacing Cable Oscor Connector
K200674 · Atrility Medical, LLC · Jul 2020
Patient Monitoring Cable (SpO2 Extension Cable)
K192404 · Shenzhen Coreray Technology, Ltd. · Jun 2020
Disposable ECG Cable
K200026 · Shenzhen Changke Connect Electronics Co., Ltd. · May 2020